0001209191-23-046152.txt : 20230816 0001209191-23-046152.hdr.sgml : 20230816 20230816205351 ACCESSION NUMBER: 0001209191-23-046152 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230816 FILED AS OF DATE: 20230816 DATE AS OF CHANGE: 20230816 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stalfort John A III CENTRAL INDEX KEY: 0001709418 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39536 FILM NUMBER: 231179642 MAIL ADDRESS: STREET 1: C/O ACUMEN PHARMACEUTICALS, INC. STREET 2: 427 PARK STREET CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 FORMER NAME: FORMER CONFORMED NAME: Stalfort Sean DATE OF NAME CHANGE: 20170615 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Taysha Gene Therapies, Inc. CENTRAL INDEX KEY: 0001806310 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 843199512 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3000 PEGASUS PARK DRIVE STREET 2: SUITE 1430 CITY: DALLAS STATE: TX ZIP: 75247 BUSINESS PHONE: (214) 612-0000 MAIL ADDRESS: STREET 1: 3000 PEGASUS PARK DRIVE STREET 2: SUITE 1430 CITY: DALLAS STATE: TX ZIP: 75247 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-08-16 0 0001806310 Taysha Gene Therapies, Inc. TSHA 0001709418 Stalfort John A III C/O TAYSHA GENE THERAPIES, INC. 3000 PEGASUS PARK DRIVE, SUITE 1430 DALLAS TX 75247 1 0 0 0 0 Common Stock 2023-08-16 4 P 0 388889 0.90 A 884290 I See footnote Common Stock 2023-08-16 4 P 0 388889 0.90 A 999381 D Common Stock 2023-08-16 4 G 0 50000 0.00 A 1049381 D The securities are held by Gineane Holly Stalfort, as Trustee of the John A. Stalfort III 2018 Irrevocable Trust under agreement dated as of October 25, 2018. /s/ Kamran Alam, Attorney-in-Fact 2023-08-16